48
Views
16
CrossRef citations to date
0
Altmetric
Original

PROLACTIN STIMULATION IN MULTIPLE SCLEROSIS – AN INDICATOR OF DISEASE SUBTYPES AND ACTIVITY?

, , , &
Pages 9-18 | Published online: 07 Jul 2009

REFERENCES

  • Morgan P. J. The Pars Tuberalis: The Missing Link in the Photoperiodic Regulation of Prolactin Secretion?. J. Neuroendocrinol. 2000; 12: 287–295
  • Walton P. E., Cronin M. J. TNFalpha and IFNgama Reduce PRL Releasein vitro. Am. J. Physiol. 1990; 259: 672–676
  • Clevenger C. V., Sillman A. L., Hanley-Hide J., Rytowsky M. B. Requirement for Prolactin During Cell Cycle Regulated Gene Expression in Cloned T Lymphocytes. Endocrinology 1992; 130: 3216–3222
  • Bernton E. W., Meltzer M. S., Holaday J. W. Suppression of Macrophage Activation and T Lymphocyte Function in Hypoprolactinemic Mice. Science 1988; 239: 401–404
  • Chikanza I. C. Prolactin and Neuroimmunomodulation:in vitroandin vivoObservations. Ann. NY Acad. Sci. 1999; 876: 119–130
  • Draca S., Levic Z. The Possible Role of Prolactin in the Immunopathogenesis of Multiple Sclerosis. Med. Hypoth. 1996; 47: 89–92
  • Neidhardt M. Prolactin and Autoimmune Diseases. Proceedings of the Society of Experimental Biol. Med. 1998; 217: 408–419
  • Riskind P. N., Massacesi L., Doolittle T. H., Hauser S. L. The Role of Prolactin in Autoimmune Demyelination: Suppression of Experimental Allergic Encephalomyelitis by Bromocriptine. Ann. Neurol. 1991; 29: 542–547
  • Dijkstra C. D., Rouppe E. van der Voort, De Groot C.J. A., Huitinga I, Uitdehaag B.M. J., Polman C. H., Berkenbosch F. Therapeutic Effect of the D2-Dopamine Agonist Bromocriptine on Acute and Allergic Experimental Encephalomyelitis. Psychoneuroendocrinology 1994; 19: 135–142
  • Kira J., Harada M., Yamaguchi M., Shida N., Goto J. Hyperprolactinemia in Multiple Sclerosis. J. Neurol. Sci. 1991; 102: 61–66
  • Grinsted L., Heltberg A., Hagen C., Djursing H. Serum Sex Hormone and Gonadotropin Concentrations in Premenopausal Women with Multiple Sclerosis. J. Int. Med. 1989; 226: 241–244
  • Reder A. T., Lowy M. T. Serum Prolactin Levels in Active Multiple Sclerosis and During Cyclosporin Treatment. J. Neurol. Sci. 1993; 117: 192–196
  • Wie T., Lightman S. L. The Neuroendocrine Axis in Patinets with Multiple Sclerosis. Brain 1997; 120: 1067–1076
  • Yamasaki K., Horiuchi I., Minohara M., Osolgawa M., Kawano Y., Ohyagi Y., Yamada T., Kira J. Hyperprolactinemia in Multiple Sclerosis. Int. Med. 2000; 39: 296–299
  • Vernant J. C., Cabre P., Smadja D., Merle H., Canbarre I., Mikol J. Recurrent Optic Neuromyelitis with Endocrinopathies: A New Syndrome. Neurology 1997; 48: 58–64
  • Confavreux C., Hutchinson M., Hours M. M., Cortinois-Tourinaire P., Moreau T. and the Pregnancy in Multiple Sclerosis Group. Rate of Pregnancy Related Relapse in Multiple Sclerosis. N. Engl. J. Med. 1998; 339: 285–292
  • Lublin F. D., Reingold S. C. for the National Multiple Sclerosis Society (USA). Advisory Commitee on Clinical Trials of New Agents in Multiple Sclerosis: Defining the Clinical Course of Multiple Sclerosis: Results of an International Survey. Neurology 1996; 46: 907–911
  • Kurtzke J. M. Rating Neurological Impairment in Multiple Sclerosis: An Expanded Disability Status Scale. Neurology 1983; 33: 1444–1452
  • Mumford C., Compston A. Problems with Rating Scales for Multiple Sclerosis: A Novel Approach—the CAMBS Score. J. Neurol. 1993; 240: 209–215
  • Rotkvic I., Hrabar D., Krpan H., Banic M., Brkic T., Duvnjak M., Zjacic V., Sikiric P. Inhibition and Stimulation of Prolactin Release. Delayed Response in Duodenal Ulcer Patients. Dig. Dis. Sci. 1992; 37: 1815–1819
  • Anderson B. L., Farrar W. B., Golden-Kreutz D., Katz L. A., MacCallum R., Courtney M. E. Stress and Immune Responses After Surgical Treatment for Regional Breast Cancer. J. Nat. Cancer Inst. 1998; 90: 30–36
  • Grasser A., Möller A., Backmund A., Yassouridis A., Holsboer F. Heterogeneity of Hypothalamic-Pituitary-Adrenal System Response to a Combined Dexamethasone-CRH Test in Multiple Sclerosis. Exp. Clin. Endocrinol. 1996; 104: 31–37
  • Azar S. T., Yamout B. Prolactin Secretion is Increased in Patients with Multiple Sclerosis. Endocri. Res. 1999; 25: 207–214
  • Lucchinetti C., Brück W., Parisis I., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of MS Lesions: Implications for the Pathogenesis of Demyelination. Ann. Neurol. 2000; 47: 707–717
  • McMurray R. W., Weidensaul D., Allen S. H., Walker S. E. Efficiacy of Bromocriptine in an Open Labeled Therapeutic Trial for Systemic Lupus Erythematosus. J. Rheumtol. 1995; 22: 2084–2091

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.